Your browser doesn't support javascript.
loading
Resistance to PI3Kδ inhibitors in marginal zone lymphoma can be reverted by targeting the IL-6/PDGFRA axis.
Arribas, Alberto J; Napoli, Sara; Cascione, Luciano; Sartori, Giulio; Barnabei, Laura; Gaudio, Eugenio; Tarantelli, Chiara; Mensah, Afua Adjeiwaa; Spriano, Filippo; Zucchetto, Antonella; Rossi, Francesca M; Rinaldi, Andrea; Castro de Moura, Manuel; Jovic, Sandra; Bordone-Pittau, Roberta; Di Veroli, Alessandra; Stathis, Anastasios; Cruciani, Gabriele; Stussi, Georg; Gattei, Valter; Brown, Jennifer R; Esteller, Manel; Zucca, Emanuele; Rossi, Davide; Bertoni, Francesco.
Afiliação
  • Arribas AJ; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland; SIB Swiss Institute of Bioinformatics, Lausanne. alberto.arribas@ior.usi.ch.
  • Napoli S; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona.
  • Cascione L; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland; SIB Swiss Institute of Bioinformatics, Lausanne.
  • Sartori G; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona.
  • Barnabei L; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona.
  • Gaudio E; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona.
  • Tarantelli C; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona.
  • Mensah AA; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona.
  • Spriano F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona.
  • Zucchetto A; Centro di Riferimento Oncologico di Aviano - CRO, Aviano.
  • Rossi FM; Centro di Riferimento Oncologico di Aviano - CRO, Aviano.
  • Rinaldi A; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona.
  • Castro de Moura M; Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalunya.
  • Jovic S; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona.
  • Bordone-Pittau R; Oncology Institute of Southern Switzerland, Bellinzona.
  • Di Veroli A; Department of Chemistry, Biology and Biotechnology, University of Perugia, Perugia.
  • Stathis A; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Faculty of Biomedical Sciences, USI, Bellinzona.
  • Cruciani G; Department of Chemistry, Biology and Biotechnology, University of Perugia, Perugia.
  • Stussi G; Oncology Institute of Southern Switzerland, Bellinzona.
  • Gattei V; Centro di Riferimento Oncologico di Aviano - CRO, Aviano.
  • Brown JR; Chronic Lymphocytic Leukemia Center, Division of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.
  • Esteller M; Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain; Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain; Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain; Physiological Sciences Department, School of Me
  • Zucca E; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland; Oncology Institute of Southern Switzerland, Bellinzona.
  • Rossi D; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland; Oncology Institute of Southern Switzerland, Bellinzona.
  • Bertoni F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland; Oncology Institute of Southern Switzerland, Bellinzona. francesco.bertoni@ior.usi.ch.
Haematologica ; 107(11): 2685-2697, 2022 11 01.
Article em En | MEDLINE | ID: mdl-35484662

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Linfoma de Zona Marginal Tipo Células B / MicroRNAs Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Linfoma de Zona Marginal Tipo Células B / MicroRNAs Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2022 Tipo de documento: Article